Kayne Anderson Rudnick Investment Management LLC Charles River Laboratories International, Inc. Transaction History
Kayne Anderson Rudnick Investment Management LLC
- $41.6 Billion
- Q4 2024
A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 1,805,541 shares of CRL stock, worth $293 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
1,805,541
Previous 1,939,825
6.92%
Holding current value
$293 Million
Previous $382 Million
12.78%
% of portfolio
0.8%
Previous 0.87%
Shares
28 transactions
Others Institutions Holding CRL
# of Institutions
708Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$999 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$826 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$661 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$354 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$293 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.25B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...